Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 2Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Glioma 1Glioblastoma 1Endometrial Neoplasms 1Colonic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3Fluorouracil 3Oxaliplatin 2Leucovorin 2Cholecalciferol 2Cetuximab 2sodium thiosulfate 1nilotinib 1gallium 68 PSMA-11 1epigallocatechin gallate 1delta-8-tetrahydrocannabinol 1clevudine 1X-Rays 1Vaccines 1Tea 1Specimen Handling 1Reverse Transcriptase Polymerase Chain Reaction 1Receptor Protein-Tyrosine Kinases 1Radiotherapy 1Platinum 1Pentoxifylline 1Panitumumab 1Microscopy, Electron 1Metastasectomy 1Irinotecan 1Hyperthermic Intraperitoneal Chemotherapy 1Granulocyte-Macrophage Colony-Stimulating Factor 1Folfox protocol 1Fluorodeoxyglucose F18 1FAPI-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Colonic Neoplasms × Dasatinib × Clear all
NCT00835679 2014-05-23

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Terminated
9 enrolled 3 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡